Vincristine Sulfate & Febrile neutropenia

18.8%

of users reported Febrile neutropenia

54.4%

also reported Hospitalization

58.4%

are men

Hospitalization

54.4%

Severe reaction

27.0%

Life-threatening condition

18.1%

Death

0.5%

Vincristine Sulfate: general information

0 - 9 years

20.9%

10 - 19 years

16.1%

20 - 29 years

8.0%

30 - 39 years

8.5%

40 - 49 years

7.4%

50 - 59 years

8.4%

60 - 69 years

18.6%

70 - 79 years

11.2%

80 - 89 years

1.1%